Literature DB >> 27190180

VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.

Justin Yai Alamou Doritchamou1, Raul Herrera1, Joan A Aebig1, Robert Morrison2, Vu Nguyen1, Karine Reiter1, Richard L Shimp1, Nicholas J MacDonald1, David L Narum1, Michal Fried1, Patrick E Duffy1.   

Abstract

BACKGROUND: Placental malaria is caused by Plasmodium falciparum-infected erythrocytes (IEs) that surface-express VAR2CSA and bind chondroitin sulfate A. The inflammatory response to placenta-sequestered parasites is associated with poor pregnancy outcomes, and protection may be mediated in part by VAR2CSA antibodies that block placental IE adhesion.
METHODS: In this study, we used a new approach to assess VAR2CSA domains for functional epitopes recognized by naturally acquired antibodies. Antigen-specific immunoglobulin (Ig) G targeting Duffy binding-like (DBL) domains from different alleles were sequentially purified from plasma pooled from multigravid women and then characterized using enzyme-linked immunosorbent assay, flow cytometry, and antiadhesion assays.
RESULTS: Different DBL domain-specific IgGs could react to homologous as well as heterologous antigens and parasites, suggesting that conserved epitopes are shared between allelic variants. Homologous blocking of IE binding was observed with ID1-DBL2-ID2a-, DBL4-, and DBL5-specific IgG (range, 42%-75%), whereas partial cross-inhibition activity was observed with purified IgG specific to ID1-DBL2-ID2a and DBL4 antigens. Plasma retained broadly neutralizing activity after complete depletion of these VAR2CSA specificities.
CONCLUSIONS: Broadly neutralizing antibodies of multigravidae are not depleted on VAR2CSA recombinant antigens, and hence development of VAR2CSA vaccines based on a single construct and variant might induce antibodies with limited broadly neutralizing activity. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  DBL domains; VAR2CSA; functional antibody; malaria; multigravidae; pregnancy; vaccine

Mesh:

Substances:

Year:  2016        PMID: 27190180      PMCID: PMC4957442          DOI: 10.1093/infdis/jiw197

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women.

Authors:  Pamela A Magistrado; Daniel Minja; Justin Doritchamou; Nicaise Tuikue Ndam; Davis John; Christentze Schmiegelow; Achille Massougbodji; Madeleine Dahlbäck; Sisse B Ditlev; Vera V Pinto; Mafalda Resende; John Lusingu; Thor G Theander; Ali Salanti; Morten A Nielsen
Journal:  Vaccine       Date:  2010-11-12       Impact factor: 3.641

2.  An analysis of malaria in pregnancy in Africa.

Authors:  B J Brabin
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

3.  Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women.

Authors:  N G Tuikue Ndam; A Salanti; J-Y Le-Hesran; G Cottrell; N Fievet; L Turner; S Sow; J-M Dangou; T Theander; P Deloron
Journal:  J Infect Dis       Date:  2006-01-30       Impact factor: 5.226

4.  Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy.

Authors:  I O'Neil-Dunne; R N Achur; S T Agbor-Enoh; M Valiyaveettil; R S Naik; C F Ockenhouse; A Zhou; R Megnekou; R Leke; D W Taylor; D C Gowda
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes.

Authors:  Pamela Magistrado; Ali Salanti; Nicaise G Tuikue Ndam; Steven B Mwakalinga; Mafalda Resende; Madeleine Dahlbäck; Lars Hviid; John Lusingu; Thor G Theander; Morten A Nielsen
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

6.  Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns.

Authors:  Patrick E Duffy; Michal Fried
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Six genes are preferentially transcribed by the circulating and sequestered forms of Plasmodium falciparum parasites that infect pregnant women.

Authors:  Susan E Francis; Vladislav A Malkov; Andrew V Oleinikov; Eddie Rossnagle; Jason P Wendler; Theonest K Mutabingwa; Michal Fried; Patrick E Duffy
Journal:  Infect Immun       Date:  2007-08-13       Impact factor: 3.441

8.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

9.  Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.

Authors:  Thomas M Clausen; Stig Christoffersen; Madeleine Dahlbäck; Annette Eva Langkilde; Kamilla E Jensen; Mafalda Resende; Mette Ø Agerbæk; Daniel Andersen; Besim Berisha; Sisse B Ditlev; Vera V Pinto; Morten A Nielsen; Thor G Theander; Sine Larsen; Ali Salanti
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

10.  Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.

Authors:  Marion Avril; Bridget R Kulasekara; Severin O Gose; Chris Rowe; Madeleine Dahlbäck; Patrick E Duffy; Michal Fried; Ali Salanti; Lynda Misher; David L Narum; Joseph D Smith
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

View more
  16 in total

1.  Functional Antibodies against Placental Malaria Parasites Are Variant Dependent and Differ by Geographic Region.

Authors:  Justin Doritchamou; Andrew Teo; Robert Morrison; Gunjan Arora; Jennifer Kwan; Javier Manzella-Lapeira; Sarimar Medina-Maldonado; Jean Langhorne; Lars Hviid; David L Narum; Alassane Dicko; Michal Fried; Patrick E Duffy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

2.  Expression of Large Full-Length PfEMP1 Proteins in HEK293 Cells.

Authors:  Jonathan Paul Renn; Justin Yai Alamou Doritchamou; Patrick Emmet Duffy
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Severe malaria: what's new on the pathogenesis front?

Authors:  Samuel Crocodile Wassmer; Georges Emile Raymond Grau
Journal:  Int J Parasitol       Date:  2016-09-23       Impact factor: 3.981

4.  Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.

Authors:  Rui Ma; Tengfei Lian; Rick Huang; Jonathan P Renn; Jennifer D Petersen; Joshua Zimmerberg; Patrick E Duffy; Niraj H Tolia
Journal:  Nat Microbiol       Date:  2021-01-15       Impact factor: 17.745

5.  Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes.

Authors:  Michal Fried; Jonathan D Kurtis; Bruce Swihart; Robert Morrison; Sunthorn Pond-Tor; Amadou Barry; Youssoufa Sidibe; Sekouba Keita; Almahamoudou Mahamar; Naissem Andemel; Oumar Attaher; Adama B Dembele; Kadidia B Cisse; Bacary S Diarra; Moussa B Kanoute; David L Narum; Alassane Dicko; Patrick E Duffy
Journal:  Malar J       Date:  2018-03-09       Impact factor: 2.979

6.  NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity.

Authors:  Gunjan Arora; Geoffrey T Hart; Javier Manzella-Lapeira; Justin Ya Doritchamou; David L Narum; L Michael Thomas; Joseph Brzostowski; Sumati Rajagopalan; Ogobara K Doumbo; Boubacar Traore; Louis H Miller; Susan K Pierce; Patrick E Duffy; Peter D Crompton; Sanjay A Desai; Eric O Long
Journal:  Elife       Date:  2018-06-26       Impact factor: 8.140

7.  Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between Plasmodium vivax PvDBP and Plasmodium falciparum VAR2CSA.

Authors:  Catherine J Mitran; Angie Mena; Sedami Gnidehou; Shanna Banman; Eliana Arango; Barbara A S Lima; Hazel Lugo; Aravindhan Ganesan; Ali Salanti; Anthony K Mbonye; Francis Ntumngia; Khaled Barakat; John H Adams; Flora S Kano; Luzia H Carvalho; Amanda E Maestre; Michael F Good; Stephanie K Yanow
Journal:  mBio       Date:  2019-10-08       Impact factor: 7.867

8.  Generation of a Peptide Vaccine Candidate against Falciparum Placental Malaria Based on a Discontinuous Epitope.

Authors:  Catherine J Mitran; Lauren M Higa; Michael F Good; Stephanie K Yanow
Journal:  Vaccines (Basel)       Date:  2020-07-18

9.  Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.

Authors:  Mirja Hommel; Jo-Anne Chan; Alexandra J Umbers; Christine Langer; Stephen J Rogerson; Joseph D Smith; James G Beeson
Journal:  Parasit Vectors       Date:  2018-01-29       Impact factor: 3.876

10.  mSphere of Influence: Structural Insights into the Molecular Mechanism Underlying Placental Malaria.

Authors:  Maria Del Pilar Quintana
Journal:  mSphere       Date:  2021-05-28       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.